| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06649331 | Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer | Advanced Breast Cancer | Recruiting |
| NCT05582499 | Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study… | Breast Neoplasm | Recruiting |
| NCT07353437 | Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination… | Breast Cancer | Not Yet Recruiting |
| NCT07355010 | A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib… | Ovarian Cancer | Not Yet Recruiting |
| NCT07382713 | Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced… | Ovarian Cancer | Not Yet Recruiting |
| NCT07517653 | Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable… | Melanoma | Not Yet Recruiting |